interferon alpha 2 application in treatment for acute respiratory viral infections among children
Clicks: 124
ID: 223110
2007
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
124 views
19 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #47 of 111 articles by views in Biocontrol science
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The authors studied the clinical efficiency and safety of interferon alpha-2 (Reaferon-Es-Lipint) in oral dosing within complex therapy for acute respiratory viral infections. Dynamics of the main clinical and laboratory symptoms proves high efficiency of a medication and expediency of its use for the treatment of acute respiratory viral infections among children.
Key words: children, acute respiratory viral infections, treatment, interferon alpha 2.
Key words: children, acute respiratory viral infections, treatment, interferon alpha 2.
| Reference Key |
petrov2007voprosyinterferon
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;V.A. Petrov;T.V. Tsopa;T.O. Medvedeva;A.A. Arova;S.N. Targonsky;S.V. Usova |
| Journal | Biocontrol science |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.